-+ 0.00%
-+ 0.00%
-+ 0.00%

Richter Targets GenMed Revenue Above EUR 1.3 Billion by 2035

PUBT·11/10/2026 05:05:41
Richter Targets GenMed Revenue Above EUR 1.3 Billion by 2035
  • Gedeon Richter targets doubling its non-royalty business by 2035, with women's healthcare becoming its largest clean EBIT contributor.
  • Women's healthcare revenue is targeted to double from EUR 826 million in 2025, supported by portfolio growth and new launches.
  • General Medicines aims for revenue above EUR 1.3 billion by 2035, versus EUR 634 million in 2024.
  • The division targets a clean EBIT margin above 20% by 2030, up from 16% in 2024.
  • Biotechnology targets break-even by 2027, supported by double-digit revenue growth and eight internally developed product launches.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gedeon Richter plc published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.